Abstract
The impact of early and late age-related macular degeneration (AMD) on quality of life (QoL) has been comprehensively assessed to date (Lamoureux et al. 2011; Wong et al. 2004; Espallargues et al. 2005; Finger et al. 2011a; Mangione et al. 1999). Early stages of the disease are associated with little functional loss (i.e. normal visual acuity) and few symptoms. However, the prognosis is poor for most patients affected by either atrophic or neovascular late-stage AMD. In the late-stage condition, central vision can be severely impaired, leading to a central scotoma. The implications of this level of visual impairment on daily functioning activities include inability to read, watch TV, recognise faces or do manual work requiring near central vision (Birk et al. 2004). Vision impairment associated with AMD also impacts on falls, mobility and emotional well-being (Parrish et al. 1997; Mackenzie et al. 2002). However, to understand the impact of AMD on QoL, it is important to consider vision loss not in isolation, but in the context of a patient’s ability to adapt and cope (Slakter and Stur 2005). For example, functional difficulties can be partly alleviated by using magnifying glasses, screen-projection devices such as CCTVs and other low-vision aids and devices. Despite this, patients with late-stage AMD remain severely limited in undertaking many everyday activities. As highlighted in previous chapters (e.g. Chap. 3), the incidence of AMD is projected to increase due to current demographic trends, but less cases may progress to the more severe late stages due to treatment and other unknown factors in high-income countries. Thus, a large proportion of the elderly population is likely to experience serious QoL detriments associated with AMD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aaronson NK (1988) Quality of life: what is it? How should it be measured? Oncology (Williston Park) 2(5):69–76, 64
Armbrecht AM, Aspinall PA, Dhillon B (2004) A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration. Br J Ophthalmol 88(10):1270–1273
Birk T, Hickl S, Wahl HW, Miller D, Kammerer A, Holz F et al (2004) Development and pilot evaluation of a psychosocial intervention program for patients with age-related macular degeneration. Gerontologist 44(6):836–843
Bond TG, Fox CM (2001) Applying the Rasch Model: fundamental measurement in the human sciences. Lawrence Erlbaum Associates, London
Bressler NM, Chang TS, Suner IJ, Fine JT, Dolan CM, Ward J et al (2010) Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR. Ophthalmology 117(4):747–756 e4
Brody BL, Williams RA, Thomas RG, Kaplan RM, Chu RM, Brown SI (1999) Age-related macular degeneration: a randomized clinical trial of a self-management intervention. Ann Behav Med 21(4):322–329
Brody BL, Gamst AC, Williams RA, Smith AR, Lau PW, Dolnak D et al (2001) Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 108(10):1893–1900; discussion 900–901
Broman AT, Munoz B, Rodriguez J, Sanchez R, Quigley HA, Klein R et al (2002) The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci 43(11):3393–3398
Brown MM, Brown GC, Sharma S, Landy J, Bakal J (2002) Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol 120(4):481–484
Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N (2002) Patient reported outcomes: the example of health-related quality of life – a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf J 36:209–238
Committee for Medicinal Products for Human Use (CHMP) (2005) Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. EMEA, London
de Boer MR, Moll AC, de Vet HC, Terwee CB, Volker-Dieben HJ, van Rens GH (2004) Psychometric properties of vision-related quality of life questionnaires: a systematic review. Ophthalmic Physiol Opt 24(4):257–273
DeCarlo DK, Scilley K, Wells J, Owsley C (2003) Driving habits and health-related quality of life in patients with age-related maculopathy. Optom Vis Sci 80(3):207–213
Denny F, Marshall AH, Stevenson MR, Hart PM, Chakravarthy U (2007) Rasch analysis of the daily living tasks dependent on vision (DLTV). Invest Ophthalmol Vis Sci 48(5):1976–1982
Dong LM, Childs AL, Mangione CM, Bass EB, Bressler NM, Hawkins BS et al (2004) Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. Am J Ophthalmol 138(1):91–108
du Toit R, Palagyi A, Ramke J, Brian G, Lamoureux EL (2010) The impact of reduced distance and near vision on the quality of life of adults in Timor-Leste. Ophthalmology 117:2308–2314
Espallargues M, Czoski-Murray CJ, Bansback NJ, Carlton J, Lewis GM, Hughes LA et al (2005) The impact of age-related macular degeneration on health status utility values. Invest Ophthalmol Vis Sci 46(11):4016–4023
Finger RP, Fleckenstein M, Scholl HP, Holz FG (2007) Therapeutic anti-VEGF in ophthalmology: physiopathology and treatment of age-related macular degeneration. Pharm Unserer Zeit 36(6):424–430
Finger RP, Fleckenstein M, Holz FG, Scholl HP (2008a) Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools. Qual Life Res 17(4):559–574
Finger RP, Scholl HP, Holz FG (2008b) ”Patient reported outcomes” – Relevanz und Anwendung in der Augenheilkunde. Ophthalmologe 105(8):722–726
Finger RP, Fenwick E, Marella M, Dirani M, Holz FG, Chiang PP et al (2011a) The impact of vision impairment on vision-specific quality of life in Germany. Invest Ophthalmol Vis Sci 52(6):3613–3619
Finger RP, Fenwick E, Marella M, Charbel Issa P, Scholl HP, Holz FG et al (2011b) The relative impact of vision impairment and cardiovascular disease on quality of life: the example of pseudoxanthoma elasticum. Health Qual Life Outcomes 9(1):113
Finger RP, Fenwick E, Owsley C, Holz FG, Lamoureux EL (2011c) Visual functioning and quality of life under low luminance: evaluation of the German Low Luminance Questionnaire. Invest Ophthalmol Vis Sci 52(11):8241–8249
Finger RP, Fenwick E, Chiang PP, Petrak M, Holz FG, Marella M et al (2011d) The impact of the severity of vision loss on vision-specific functioning in a German outpatient population – an observational study. Graefes Arch Clin Exp Ophthalmol 249(8):1245–1253
Garamendi E, Pesudovs K, Stevens MJ, Elliott DB (2006) The Refractive Status and Vision Profile: evaluation of psychometric properties and comparison of Rasch and summated Likert-scaling. Vision Res 46:1375–1383
Gothwal VK, Wright TA, Lamoureux EL, Pesudovs K (2011) Multiplicative rating scales do not enable measurement of vision-related quality of life. Clin Exp Optom 94(1):52–62
Hirneiss C, Rombold F, Kampik A, Neubauer AS (2006) Visual quality of life after vitreoretinal surgery for epiretinal membranes. Ophthalmologe 103(2):109–113
Hirneiss C, Neubauer AS, Gass CA, Reiniger IW, Priglinger SG, Kampik A et al (2007) Visual quality of life after macular hole surgery: outcome and predictive factors. Br J Ophthalmol 91(4):481–484
Horowitz A, Reinhardt JP, Boerner K, Travis LA (2003) The influence of health, social support quality and rehabilitation on depression among disabled elders. Aging Ment Health 7(5):342–350
Ivanoff SD, Sjostrand J, Klepp KI, Lind LA, Lindqvist BL (1996) Planning a health education programme for the elderly visually impaired person – a focus group study. Disabil Rehabil 18(10):515–522
Jenkins GDJ, Taber TD (1977) A Monte-Carlo study of factors affecting three indices of composite scale reliability. J Appl Psychol 62:392–398
Knudtson MD, Klein BE, Klein R, Cruickshanks KJ, Lee KE (2005) Age-related eye disease, quality of life, and functional activity. Arch Ophthalmol 123(6):807–814
Lamoureux E, Pesudovs K (2011) Vision-specific quality-of-life research: a need to improve the quality. Am J Ophthalmol 151(2):195–197 e2
Lamoureux EL, Pallant JF, Pesudovs K, Hassell JB, Keeffe JE (2006) The impact of vision impairment questionnaire: an evaluation of its measurement properties using Rasch analysis. Invest Ophthalmol Vis Sci 47(11):4732–4741
Lamoureux EL, Pallant JF, Pesudovs K, Rees G, Hassell JB, Keeffe JE (2007a) The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and Rasch analysis. Invest Ophthalmol Vis Sci 48(3):1001–1006
Lamoureux EL, Pallant JF, Pesudovs K, Rees G, Hassell JB, Keeffe JE (2007b) The effectiveness of low-vision rehabilitation on participation in daily living and quality of life. Invest Ophthalmol Vis Sci 48(4):1476–1482
Lamoureux EL, Pallant JF, Pesudovs K, Tennant A, Rees G, O’Connor PM et al (2008a) Assessing participation in daily living and the effectiveness of rehabilitation in age related macular degeneration patients using the impact of vision impairment scale. Ophthalmic Epidemiol 15(2):105–113
Lamoureux EL, Chong E, Wang JJ, Saw SM, Aung T, Mitchell P et al (2008b) Visual impairment, causes of vision loss, and falls: the Singapore Malay eye study. Invest Ophthalmol Vis Sci 49(2):528–533
Lamoureux EL, Chong EW, Thumboo J, Wee HL, Wang JJ, Saw SM et al (2008c) Vision impairment, ocular conditions, and vision-specific function: the Singapore Malay Eye study. Ophthalmology 115(11):1973–1981
Lamoureux EL, Mitchell P, Rees G, Cheung G, Yeo I, Lee SY et al (2011) Impact of early and late age-related macular degeneration on vision-specific functioning. Br J Ophthalmol 95(5):666–670
Langelaan M, van Nispen RM, Knol DL, Moll AC, de Boer MR, Wouters B et al (2007) Visual Functioning Questionnaire: reevaluation of psychometric properties for a group of working-age adults. Optom Vis Sci 84(8):775–784
Lindblad AS, Clemons TE (2005) Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS report no. 14. Arch Ophthalmol 123(9):1207–1214
Lissitz RW, Green SB (1975) The effect of the number of scale points in reliability: a Monte-Carlo approach. J Appl Psychol 60:10–13
Mackenzie PJ, Chang TS, Scott IU, Linder M, Hay D, Feuer WJ et al (2002) Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology 109(4):720–729
Mangione CM, Gutierrez PR, Lowe G, Orav EJ, Seddon JM (1999) Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol 128(1):45–53
Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD (2001) Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 119(7):1050–1058
Marella M, Pesudovs K, Keeffe JE, O’Connor PM, Rees G, Lamoureux EL (2010) The psychometric validity of the NEI VFQ-25 for use in a low-vision population. Invest Ophthalmol Vis Sci 51(6):2878–2884
Massof RW, Fletcher DC (2001) Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Res 41(3):397–413
Massof RW, Hsu CT, Baker FH, Barnett GD, Park WL, Deremeik JT et al (2005) Visual disability variables. I: the importance and difficulty of activity goals for a sample of low-vision patients. Arch Phys Med Rehabil 86(5):946–953
Mitchell J, Bradley C (2004) Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL). Qual Life Res 13(6):1163–1175
Mitchell J, Wolffsohn JS, Woodcock A, Anderson SJ, McMillan CV, Ffytche T et al (2005) +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life. Health Qual Life Outcomes 3:25
Norquist JM, Fitzpatrick R, Dawson J, Jenkinson C (2004) Comparing alternative Rasch-based methods vs raw scores in measuring change in health. Med Care 42(1 Suppl):I25–I36
O’Shaughnessy JA, Wittes RE, Burke G, Friedman MA, Johnson JR, Niederhuber JE et al (1991) Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. J Clin Oncol 9(12):2225–2232
Owsley C, McGwin G Jr, Scilley K, Kallies K (2006a) Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy. Invest Ophthalmol Vis Sci 47(2):528–535
Owsley C, McGwin G, Jackson GR, Heimburger DC, Piyathilake CJ, Klein R et al (2006b) Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy. Invest Ophthalmol Vis Sci 47(4):1310–1318
Owsley C, McGwin G Jr, Jackson GR, Kallies K, Clark M (2007) Cone- and rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmology 114(9):1728–1735
Parrish RK, Gedde SJ, Scott IU, Feuer WJ, Schiffman JC, Mangione CM et al (1997) Visual function and quality of life among patients with glaucoma. Arch Ophthalmol 115(11):1447–1455
Pesudovs K (2004) Autorefraction as an outcome measure of laser in situ keratomileusis. J Cataract Refract Surg 30(9):1921–1928
Pesudovs K (2006) Patient-centred measurement in ophthalmology – a paradigm shift. BMC Ophthalmol 6(1):25
Pesudovs K, Garamendi E, Keeves JP, Elliott DB (2003) The Activities of Daily Vision Scale for cataract surgery outcomes: re-evaluating validity with Rasch analysis. Invest Ophthalmol Vis Sci 44(7):2892–2899
Pesudovs K, Burr JM, Harley C, Elliott DB (2007) The development, assessment, and selection of questionnaires. Optom Vis Sci 84(8):663–674
Revicki DA, Cella DF (1997) Health status assessment for the twenty-first century: item response theory, item banking and computer adaptive testing. Qual Life Res 6(6):595–600
Rovner BW, Ganguli M (1998) Depression and disability associated with impaired vision: the MoVIES project. J Am Geriatr Soc 46(5):617–619
Rovner BW, Zisselman PM, ShmuelyDulitzki Y (1996) Depression and disability in older people with impaired vision: a follow-up study. J Am Geriatr Soc 44(2):181–184
Rovner BW, Casten RJ, Tasman WS (2002) Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol 120(8):1041–1044
Rubin GS, Roche KB, Prasada-Rao P, Fried LP (1994) Visual impairment and disability in older adults. Optom Vis Sci 71(12):750–760
Scheibler F, Finger RP, Grosselfinger R, Dintsios CM (2010) Patient-reported and patient-weighted outcomes in ophthalmology. Ophthalmologe 107(3):235–240
Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C (2002) Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology 109(7):1235–1242
Scott IU, Smiddy WE, Schiffman J, Feuer WJ, Pappas CJ (1999) Quality of life of low-vision patients and the impact of low-vision services. Am J Ophthalmol 128(1):54–62
Sharma S, Brown GC, Brown MM, Hollands H, Shah GK (2001) The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 108(11):2051–2059
Slakter JS, Stur M (2005) Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment. Surv Ophthalmol 50(3):263–273
Tolman J, Hill RD, Kleinschmidt JJ, Gregg CH (2005) Psychosocial adaptation to visual impairment and its relationship to depressive affect in older adults with age-related macular degeneration. Gerontologist 45(6):747–753
Velozo CA, Lai JS, Mallinson T, Hauselman E (2000) Maintaining instrument quality while reducing items: application of Rasch analysis to a self-report of visual function. J Outcome Meas 4(3):667–680
Weih LM, Hassell JB, Keeffe JE (2002) Assessment of the impact of vision impairment. Invest Ophthalmol Vis Sci 43(4):927–935
Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI (1998) The psychosocial impact of macular degeneration. Arch Ophthalmol 116(4):514–520
Wong EYH, Guymer RH, Hassell J, Keeffe J (2004) The experience of age-related macular degeneration. J Vis Imp Blind 98:629–640
Ying GS, Maguire MG, Liu C, Antoszyk AN (2008) Night vision symptoms and progression of age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial. Ophthalmology 115(11):1876–1882
Acknowlegments
Conflict of interest: none; Ethical standards: Informed consent – not applicable; Animal rights – not applicable.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Finger, R.P., Fenwick, E., Lamoureux, E.L. (2013). Impact of Early and Late Age-Related Macular Degeneration on Quality of Life. In: Scholl, H., Massof, R., West, S. (eds) Ophthalmology and the Ageing Society. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-36324-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-36324-5_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36323-8
Online ISBN: 978-3-642-36324-5
eBook Packages: MedicineMedicine (R0)